Aperio Group, LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 152 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2015. The put-call ratio across all filers is 2.14 and the average weighting 0.7%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$1,792,000
+6.2%
41,461
+3.8%
0.02%
+5.9%
Q2 2015$1,687,000
+48.5%
39,930
+36.3%
0.02%
+30.8%
Q1 2015$1,136,000
+32.6%
29,297
+15.1%
0.01%
+18.2%
Q4 2014$857,000
+72.8%
25,449
+79.6%
0.01%
+57.1%
Q3 2014$496,000
+17.5%
14,172
+10.4%
0.01%
+16.7%
Q2 2014$422,000
-23.7%
12,837
-14.4%
0.01%
-25.0%
Q1 2014$553,000
+114.3%
14,997
+122.8%
0.01%
+100.0%
Q4 2013$258,0006,7310.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders